Rigel Pharmaceuticals (RIGL) sinks 7.3% to $9.58 after pricing an offering of 13.685M shares at...


Rigel Pharmaceuticals (RIGL) sinks 7.3% to $9.58 after pricing an offering of 13.685M shares at $9.50 each, resulting in gross proceeds of $130M. The underwriters have a 30-day option to buy up to 2.05M extra shares to cover overallotments. (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs